Maryland's medical marijuana program has been put on hold before a final vote due to adjustments to licensing fees and legalization of marijuana extracts. Dr. Paul W. Davies, a chairman on the panel stated that officals are requesting more time to draft rules pertaining to concentrated forms of marijuana.
"We realized that our regulations didn't cover extracts," said Davies, a pain management specialist, "and for medical use that's incredibly important."
The commission had opted initially to focus only on growing and dispensing marijuana in leaf form, Davies said, because of the "time crunch" of meeting a Sept. 15 deadline set by the General Assembly for adopting regulations. But the panel decided to respond to public comments urging it to include extracts, he said, because for some people dosing themselves by smoking marijuana isn't feasible or comfortable.